BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 3, 2015
View Archived Issues
GlaxoSmithKline presents highlights of third quarter 2015
Read More
Taiho starts phase I trial of TAS-303 in women with stress urinary incontinence
Read More
Vertex profiles pipeline progression in third quarter 2015
Read More
Isis Pharmaceuticals begins phase II study of ISIS-FXIRx in end-stage renal disease
Read More
Alexza to regain U.S. rights to Adasuve from Teva
Read More
Quark Pharmaceuticals plans new trials of QPI-1002
Read More
Q BioMed signs definitive license agreement for Mannin's platform technology assets
Read More
T-2762 shows efficacy for the treatment of dry eye syndrome
Read More
Sylentis identifies siRNA for treating allergic conjunctivitis
Read More
Significant activity seen with ustekinumab in Crohn's disease without TNF-antagonist resistance
Read More
XuanZhu Pharma patents EGFR inhibitors
Read More
Merck & Co. and Mochida develop FIXa inhibitors
Read More
University of California at Chapel Hill reports MerTK/TYRO3 inhibitors
Read More
Aileron Therapeutics discloses PTH1R antagonists
Read More
Kainos Medicine divulges Brd4 inhibitors
Read More
The Lung Cancer Research Foundation announces the award of 28 grants
Read More
Novel gene mutations associated with disease and developmental disorders reported at ASHG
Read More
Kite Pharma begins phase II ZUMA-1 trial
Read More
Glenmark and Genzyme report clinical results for vatelizumab in multiple sclerosis
Read More
Merck & Co. receives FDA breakthrough therapy designation for Keytruda in colorectal cancer
Read More
European approval for Eylea for the treatment of visual impairment due to myopic CNV
Read More
Novel biomarkers for gastrointestinal disorders discovered
Read More
SL-401 receives E.U. orphan drug designation for blastic plasmacytoid dendritic cell neoplasm
Read More
University of Oxford starts first-in-human study of prime-boost malaria vaccine
Read More
AGTC files IND application for the treatment of achromatopsia
Read More
Shire to acquire Dyax
Read More
BMS agrees to acquire Cardioxyl Pharmaceuticals
Read More